Award Success for GEA at INTERPHEX

May 21, 2015
GEA is delighted to receive the award for Best Technologies Innovation at this year’s INTERPHEX event in New York (New York, USA).

Recognised for outstanding achievements in cutting-edge technologies, GEA was presented with the award during the show’s opening ceremony on 21 April for its standardised development and manufacturing technology platform: PCMM (Portable, Continuous, Miniature and Modular).

H. McCoy Knight, National Sales Manager, GEA Pharma Systems, noted: “The development of small-scale, continuous manufacturing (CM) systems will be one of the most significant changes in the pharmaceutical industry in the next 10 years. Flexible development options will facilitate the commercial manufacturing process and enable greater process understanding to be achieved with smaller quantities of material.” 

He continued: “To create the next generation of oral solid dosage (OSD) processing technologies and address the rapidly changing requirements of drug manufacturers, Pfizer, GEA and G-Con Manufacturing created a consortium to design and build a portable, autonomous manufacturing environment for continuous OSD production using GEA’s ConsiGma™-25 system and G-CON's modular POD system. Winning this award is welcome recognition for the effort and innovation that went into PCMM and clearly reflects excellence in pharmaceutical development and manufacturing.”

Since 1981, INTERPHEX has increasingly gained industry attention for its high-level attendees, cutting-edge technologies and networking opportunities. The inaugural INTERPHEX Exhibitor Awards were established to recognise companies that provide cutting-edge technologies and value-added solutions that enhance bio/pharmaceutical development and manufacturing and inevitably lead to business success. The ultimate goal of the awards is to celebrate innovative technologies and/or new strategies and services that transform critical and affordable life-enhancing ideas to finished drug products.

McCoy concluded: “GEA would like to thank the judges for their time and consideration, and for finding our nomination worthy of this award. I’d also like to acknowledge the invaluable contributions from Pfizer and G-CON. It’s an honour to be recognised at the very first INTERPHEX Exhibitor Awards and we look forward to participating again next year.”

 

END

 

Business enquiries to:
E-mail: pharma@gea.com 
www.gea-ps.com

 

Editorial enquiries to:
Steve Jordan
The Words Workshop Ltd
Tel. +44 1908 695500
Email: steve@thewordsworkshop.co.uk

 

Photos: GEA at INTERPHEX

 

Award success for GEA at Interphex

 


Interphex


High resolution images available from nikki@thewordsworkshop.co.uk

 

 

About GEA Group

GEA Group Aktiengesellschaft is one of the largest suppliers for the food processing industry and a wide range of other process industries. As an international technology group, the Company focuses on process technology and components for sophisticated production processes. In 2013, GEA generated consolidated revenues in excess of EUR 4.3 billion, more than 70 percent of which came from the food sector, which is a long-term growth industry. The group employed about 18,000 people worldwide as of December 31, 2013. GEA Group is a market and technology leader in its business areas. It is listed in Germany’s MDAX stock index (G1A, WKN 660 200) and the STOXX® Europe 600 Index. Further information is available on the Internet at gea.com.